Histone deacetylase inhibition by suberoylanilide hydroxamic acid during reperfusion promotes multifaceted brain and vascular protection in spontaneously hypertensive rats with transient ischaemic stroke
Hypertension is the most prevalent modifiable risk factor for stroke and is associated with worse functional outcomes. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid (SAHA) modulates gene expression and has emerged as a promising therapeutic approach to reduce...
Main Authors: | Andrea Díaz-Pérez, Belén Pérez, Gemma Manich, Julián García-Aranda, Xavier Navarro, Clara Penas, Francesc Jiménez-Altayó |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332224001689 |
Similar Items
-
In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
by: Thiemann Markus, et al.
Published: (2012-03-01) -
Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
by: Kulozik Andreas E, et al.
Published: (2011-09-01) -
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01) -
In vivo inhibitory effect of suberoylanilide hydroxamic acid combined with sorafenib on human hepatocellular carcinoma cells
by: Dalin Hao, et al.
Published: (2020-03-01) -
ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
by: Ji‐cheng Wu, et al.
Published: (2018-09-01)